| Source: |
| Type: |
| Normal cells grow and divide in a regulated manner through the cell cycle, which consists of phases (G1, S, G2, and M). Cancer cells often bypass these regulatory mechanisms, leading to uncontrolled proliferation. This can result from mutations in genes that control the cell cycle, such as oncogenes (which promote cell division) and tumor suppressor genes (which inhibit cell division). |
| 5071- | dietSTF, | Unraveling the impact of intermittent fasting in cancer prevention, mitigation, and treatment: A narrative review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 1626- | dietSTF, | dietFMD, | When less may be more: calorie restriction and response to cancer therapy |
| - | Review, | Var, | NA |
| 8840- | DIM, | Inactivation of uPA and its receptor uPAR by 3, 3'-Diindolylmethane (DIM) leads to the inhibition of Prostate Cancer Cell growth and migration |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | C4-2B | - | in-vitro, | Pca, | PC3 |
| 8836- | DIM, | Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane |
| - | vitro+vivo, | BC, | MCF7 |
| 8828- | DIM, | Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip |
| - | in-vitro, | BC, | MCF-10AT | - | in-vitro, | BC, | T47D | - | in-vitro, | BC, | BT20 | - | in-vitro, | BC, | BT474 |
| 8846- | DIM, | ORM, | Diindolylmethane Promotes Metabolic Crisis and Enhances the Efficacy of Centchroman in Breast Cancer: A 1H NMR-Based Approach |
| - | vitro+vivo, | BC, | NA |
| 8841- | DIM, | 3,3'-Diindolylmethane Suppresses the Growth of Hepatocellular Carcinoma by Regulating Its Invasion, Migration, and ER Stress-Mediated Mitochondrial Apoptosis |
| - | in-vitro, | Liver, | Hep3B | - | in-vitro, | Liver, | HUH7 |
| 4984- | Dipy, | ATV, | Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop |
| - | in-vitro, | AML, | NA |
| 6729- | Dipy, | Dipyridamole prevents triple-negative breast-cancer progression |
| - | Trial, | BC, | MDA-MB-231 |
| 6730- | Dipy, | ASA, | Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner |
| - | vitro+vivo, | CRC, | NA |
| 6270- | DL, | d-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer |
| - | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | H1299 |
| 6276- | DL, | Tam, | Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells |
| - | in-vitro, | BC, | MCF7 |
| 6328- | DRE, | Hydroalcoholic extract of Taraxacum officinale induces apoptosis and autophagy in 4T1 breast cancer cells |
| - | in-vitro, | BC, | 4T1 |
| 6343- | DRE, | Dandelion root extract affects ESCC progression via regulating multiple signal pathways |
| - | vitro+vivo, | ESCC, | NA |
| 6318- | DRE, | Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways |
| - | vitro+vivo, | CRC, | HCT116 | - | NA, | Nor, | NCM460 |
| 6327- | DRE, | Effect of Methanolic Extract of Dandelion Roots on Cancer Cell Lines and AMP-Activated Protein Kinase Pathway |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Nor, | Hs27 |
| 6360- | DRE, | Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma |
| - | in-vitro, | ESCC, | KYSE450 | - | in-vitro, | ESCC, | Eca109 |
| 6743- | DSF, | Disulfiram/Copper Activates ER Stress to Promote Immunogenic Cell Death of Oral Squamous Cell Carcinoma |
| - | in-vitro, | OS, | NA |
| 6742- | DSF, | Localized Sustained Release of Copper Enhances Anti-Tumor Effects of Disulfiram in Head and Neck Cancer |
| - | in-vitro, | HNSCC, | NA |
| 5010- | DSF, | Cu, | Rad, | Disulfiram/Copper Combined with Irradiation Induces Immunogenic Cell Death in Melanoma |
| - | in-vivo, | Melanoma, | B16-F10 |
| - | vitro+vivo, | Melanoma, | NA | - | Case Report, | Melanoma, | NA |
| 1613- | EA, | Ellagitannins in Cancer Chemoprevention and Therapy |
| - | Review, | Var, | NA |
| 27- | EA, | Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice |
| - | in-vivo, | PC, | PANC1 |
| 6801- | EA, | A radiotherapeutic paradox: ellagic acid sensitizes tumors while attenuating radiation-induced myocardial injury |
| - | vitro+vivo, | BC, | 4T1 |
| 6634- | Ech, | Echinacea purpurea: Pharmacology, phytochemistry and analysis methods |
| - | Review, | Var, | NA |
| 7237- | EGb 761, | Ginkgo biloba Extract Mechanism Inhibits Hepatocellular Carcinoma through the Nuclear Factor-κB/p53 Signaling Pathway |
| - | in-vitro, | HCC, | HepG2 |
| 7220- | EGb 761, | Ginkgo Biloba Extract Inhibits Metastasis and ERK/Nuclear Factor kappa B (NF-κB) Signaling Pathway in Gastric Cancer |
| - | vitro+vivo, | GC, | SGC-7901 |
| 6777- | EGCG, | Health Benefits and Chemical Composition of Matcha Green Tea: A Review |
| - | Review, | Nor, | NA |
| 6785- | EGCG, | Epigallocatechin-3-gallate at the nanoscale: a new strategy for cancer treatment |
| - | Review, | Var, | NA |
| 2309- | EGCG, | Chemo, | Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | Nor, | HPNE | - | in-vitro, | PC, | PANC1 | - | in-vivo, | NA, | NA |
| 2993- | EGCG, | Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells |
| - | in-vitro, | Pca, | LNCaP |
| 1514- | EGCG, | Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | MCF10 |
| 23- | EGCG, | (-)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells |
| - | in-vitro, | Chon, | SW1353 | - | in-vitro, | Chon, | CRL-7891 |
| 666- | EGCG, | The Role of EGCG in Breast Cancer Prevention and Therapy |
| - | Review, | BC, | NA |
| 655- | EGCG, | A new molecular mechanism underlying the EGCG-mediated autophagic modulation of AFP in HepG2 cells |
| - | in-vitro, | HCC, | HepG2 |
| 693- | EGCG, | CAP, | Phen, | Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol |
| - | in-vitro, | Cerv, | HeLa |
| 690- | EGCG, | Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer |
| - | in-vitro, | Pca, | NA |
| - | in-vitro, | PC, | NA |
| 5226- | EMD, | Emodin and rhein decrease levels of hypoxia-inducible factor-1α in human pancreatic cancer cells and attenuate cancer cachexia in athymic mice carrying these cells |
| - | vitro+vivo, | Pca, | MIA PaCa-2 |
| 6819- | EMD, | Recent advances in the therapeutic potential of emodin for human health |
| - | Review, | Nor, | NA |
| 6823- | EMD, | Role of emodin to prevent gastrointestinal cancers: recent trends and future prospective |
| - | Review, | Var, | NA |
| 6830- | EMD, | Anticancer activity of emodin is associated with downregulation of CD155 |
| - | vitro+vivo, | Melanoma, | B16-BL6 | - | in-vitro, | BC, | E0771 | - | in-vitro, | BC, | 4T1 |
| 6835- | EMD, | Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin |
| - | in-vitro, | BC, | NA |
| 1320- | EMD, | SRF, | Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism |
| - | vitro+vivo, | HCC, | HepG2 | - | in-vitro, | HCC, | Hep3B | - | in-vitro, | HCC, | HUH7 | - | vitro+vivo, | Hepat, | SK-HEP-1 |
| 1247- | EMD, | Emodin exerts antitumor effects in ovarian cancer cell lines by preventing the development of cancer stem cells via epithelial mesenchymal transition |
| - | vitro+vivo, | Ovarian, | SKOV3 | - | in-vitro, | Ovarian, | A2780S |
| 1245- | EMD, | Emodin Exhibits Strong Cytotoxic Effect in Cervical Cancer Cells by Activating Intrinsic Pathway of Apoptosis |
| - | in-vitro, | Cerv, | HeLa |
| 5493- | EP, | Schottky nanodiodes array enabled triboelectric nanosecond pulse generator for ultralow-cost tumor therapy |
| - | Review, | Var, | NA |
| 6793- | EPA, | Contribution of Pyk2 pathway and reactive oxygen species (ROS) to the anti-cancer effects of eicosapentaenoic acid (EPA) in PC3 prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
| 6794- | EPA, | EPA, an omega-3 fatty acid, induces apoptosis in human pancreatic cancer cells: role of ROS accumulation, caspase-8 activation, and autophagy induction |
| - | in-vitro, | BC, | NA | - | vitro+vivo, | PC, | MIA PaCa-2 |
| 6796- | EPA, | Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | Pca, | PANC1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:323 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid